Anti-VEGF therapy and subsequent hypoxia induced GM-CSF expression (Fig. 2b–d), which promoted the differentiation and migration of MDSCs in the tumour microenvironment (Fig. 5a, b). This evidence concerns the gene CSF2 and neoplasm.